Calliditas appoints new Chief Medical Officer

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that Dr. Richard Philipson has been appointed as Chief Medical Officer (CMO) of Calliditas and will be a member of the Management Team.

Richard Philipson is a physician with 24 years of experience in the pharmaceutical industry. Having worked in both large pharmaceutical companies and smaller biotechs, he has extensive experience in rare diseases, having brought several products from early development to the market.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...